Illumigyn

Illumigyn develops technology in the field of gynecology, offering a comprehensive platform solution featuring the Gynescope System, an FDA-cleared gynecology endoscope and cloud platform service. The Illumigyn Gynescope System uses a novel technology that creates high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy. The images are uploaded to the cloud for viewing and analysis by any doctor across the globe. With Illumigyn, the patient has more control and a close view of the procedure, with immediate access to a second opinion by AI clinical decision support software, without undergoing another procedure. The company aims to use its technological know-how and expertise to create an ecosystem that will empower all facets of women's health, making it accessible and affordable for every woman worldwide.

Illumigyn has raised $38M in total funding across 2 rounds. The company is currently at the A stage. Key investors include The Yozma Group, Ubicom Holdings.

Illumigyn was founded in 2012 by Ran Poliakine (Co-founder & Senior Advisor to the Board), Lior Greenstein (Co-founder, President & CTO).

Illumigyn operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Devices, Diagnostics Devices, with core technologies in Artificial Intelligence, Simulation & Imaging, Data Storage, Cloud. Target customers: Consumers, Demographics & Family, Women, Healthcare & Life Sciences, Healthcare, Providers.

Illumigyn is based in Neve Ilan, Israel, Jerusalem District.